From Lemur Gut Health to COVID-19: How Amanda Perofsky Studies Infectious Diseases

On April 21, 2026, Northeastern Global News featured Dr. Amanda Perofsky, an infectious disease ecologist at Northeastern University, whose research spans from the gut microbiomes of wild lemurs in Madagascar to the molecular epidemiology of SARS-CoV-2 variants. Her work exemplifies a growing trend in translational infectious disease science: leveraging zoonotic pathogen surveillance in wildlife reservoirs to anticipate and mitigate human pandemics. Perofsky’s longitudinal studies, which integrate genomic sequencing, behavioral ecology, and spatial modeling, have identified key spillover risks associated with habitat encroachment and climate-driven shifts in primate ranging patterns. This research is not merely academic; it directly informs early-warning systems for emerging infections and supports the development of targeted interventions at the human-animal-environment interface.

Key Clinical Takeaways:

• Perofsky’s lemur gut microbiome research reveals that anthropogenic disturbance increases pathogenic bacterial load, creating conditions conducive to zoonotic spillover.
• Her SARS-CoV-2 wastewater surveillance work in Boston demonstrated early detection of Omicron subvariants up to two weeks before clinical case surges.
• Funded by the NIH’s Ecology and Evolution of Infectious Diseases (EEID) program, her interdisciplinary model is now being adapted for use in One Health initiatives across Southeast Asia and Sub-Saharan Africa.

The core problem Perofsky addresses is the critical gap in predictive epidemiology: most outbreak responses remain reactive, triggered only after sustained human-to-human transmission has overwhelmed local health systems. By contrast, her approach targets the preclinical phase of zoonotic emergence—where pathogens circulate asymptomatically in animal populations and environmental reservoirs. In a 2023 study published in Nature Microbiology, Perofsky and colleagues analyzed fecal samples from 12 wild lemur populations across Madagascar’s fragmented forests, finding that proximity to human settlements correlated with a 3.2-fold increase in antibiotic-resistant Escherichia coli strains (n=487 samples). This dysbiosis, driven by dietary shifts and stress-induced immunosuppression, creates a fertile ground for pathogen evolution and cross-species transmission.

Building on this foundation, Perofsky pivoted to human SARS-CoV-2 surveillance during the pandemic, leading a wastewater epidemiology initiative in collaboration with the Boston Public Health Commission. Using digital PCR and variant-specific probe assays, her team monitored SARS-CoV-2 RNA concentrations in municipal sewage across 15 Boston neighborhoods from 2020 to 2022. The data, published in Environmental Science & Technology Letters in 2024, showed that wastewater signal peaks preceded clinical case reports by a median of 13 days (IQR: 9–18), providing actionable lead time for public health interventions such as targeted testing campaigns and resource allocation to overwhelmed clinics.

“What we’re seeing in the lemur gut is a mirror of what happens in human communities under ecological stress—loss of microbial diversity, rise in opportunistic pathogens, and increased permeability to cross-species jumps,” Dr. Perofsky stated in a 2025 interview with The Scientist. “Our job isn’t just to track outbreaks; it’s to detect the weakening of the barriers before they break.”

Her work has drawn praise from experts in ecological immunology and pandemic preparedness. Dr. Vanessa Ezenwa, Professor of Ecology and Evolutionary Biology at Yale University, noted in a recent commentary that “Perofsky’s integration of host physiology, environmental change, and pathogen genomics sets a new standard for mechanistic zoonotic risk prediction.” Similarly, Dr. Maria Elena Bottazzi, co-director of the Texas Children’s Hospital Center for Vaccine Development, emphasized the translational value: “Wastewater surveillance, as pioneered by teams like Amanda’s, is no longer experimental—it’s becoming a standard of care for municipal pandemic preparedness, especially in resource-limited settings where clinical testing is sparse.”

The funding behind this research is transparently anchored in federal support. Perofsky’s lemur microbiome work was primarily funded by a five-year NIH R01 grant (AI148321) from the National Institute of Allergy and Infectious Diseases (NIAID), part of the EEID program. Her SARS-CoV-2 wastewater surveillance received supplemental support through the NIH RADx-rad initiative and the Massachusetts Consortium on Pathogen Readiness (MassCPR), enabling rapid scalability during surges. This public investment underscores the importance of sustained biomedical research in building resilient public health infrastructure.

From a clinical triage perspective, Perofsky’s findings have direct implications for frontline providers and diagnostic innovators. Clinicians managing patients with unexplained gastrointestinal distress or recurrent infections in regions undergoing rapid deforestation should consider zoonotic exposure histories—a practice increasingly endorsed by the CDC’s One Health Office. For healthcare systems aiming to strengthen early detection, partnerships with environmental monitoring labs offer a force multiplier. Institutions seeking to validate wastewater-based epidemiology platforms can collaborate with vetted infectious disease specialists who interpret genomic surveillance data in clinical context. Likewise, municipal health departments navigating regulatory uncertainty around environmental sampling benefit from consulting healthcare compliance attorneys familiar with EPA and CDC guidelines on pathogen surveillance. Finally, diagnostic companies developing point-of-care nucleic acid assays for environmental samples should engage clinical reference laboratories with expertise in multiplex pathogen panels and biosafety level-2 protocols to ensure analytical validity and regulatory compliance.

Looking ahead, Perofsky’s model represents a scalable blueprint for pandemic prevention in the Anthropocene. As climate change accelerates biodiversity loss and human-wildlife contact, the require for mechanistic, ecology-informed surveillance will only grow. Future directions include integrating remote sensing data on land-use change with real-time pathogen sequencing to generate dynamic spillover risk maps—tools that could one day inform travel advisories, livestock vaccination campaigns, and targeted outreach to communities near high-risk interfaces. The ultimate goal is not just to detect outbreaks faster, but to prevent them from occurring in the first place by preserving ecological integrity.

*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*